NCT02649322

Brief Summary

Purpose of this study is to investigate the pain outcomes and satisfaction of pain relief for pediatric patients receiving needleless jet-injected (J-Tip) lidocaine prior to regional anesthesia with femoral and/or sciatic nerve block and general anesthesia for arthroscopic knee surgery compared to femoral nerve block and/or sciatic nerve block with needle injected lidocaine prior to regional and general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 3, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2015

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 7, 2016

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2019

Completed
8 months until next milestone

Results Posted

Study results publicly available

April 28, 2020

Completed
Last Updated

May 5, 2020

Status Verified

April 1, 2020

Enrollment Period

4 years

First QC Date

December 13, 2015

Results QC Date

March 3, 2020

Last Update Submit

April 27, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Baseline Pain Assessment Before Knee Arthroscopy Via the Visual Analog Scale.

    Pain will be assessed via the Visual Analog Scale by the patient before administration of the nerve block. Patient will report on a scale of 0 to 10 what their perceived pain is. 0 is no pain with 10 being worst pain patient ever experienced.

    During Baseline Assessment, Taking Approximately 20 Minutes, Before Nerve Block

  • Pain Assessment After Knee Arthroscopy Via the Visual Analog Scale

    Pain will be assess via the Visual Analog Scale by the patient after the knee arthroscopy though first post op office visit and average of one week. Patient will report on a scale of 0 to 10 what their perceived pain is. 0 is no pain with 10 being worst pain patient ever experienced.

    During Follow-up Assessment at an Average of 1 Week Post Op

Secondary Outcomes (1)

  • Satisfaction Via a 0 to 10 Rating Scale at Follow up

    At the follow up appointment, an average of one week after the procedure.

Study Arms (2)

Group A

EXPERIMENTAL

Participants in Group A will receive 0.25 mL of 1% plain lidocaine delivered by the J-tip injector at the regional block site prior to introduction of the needle for the nerve block procedure.

Device: J-Tip

Group B

ACTIVE COMPARATOR

Participants in Group B will receive 2 mL of 1% plain lidocaine injected by syringe and 25 gauge needle at the regional block site prior to introduction of the needle for the nerve block procedure.

Device: Syringe and 25 gauge needle

Interventions

J-TipDEVICE

After sterile preparation, the J-tip injector will be placed on the skin at the selected site of the regional block needle introduction. Firm pressure will be placed with the J-tip injector on the site for the chosen block, the safety ring slid down, the trigger pressed and the tip held firmly on the skin for three seconds. One quarter of a milliliter of one percent lidocaine will be injected with the characteristic "pop" and "hissing" sounds inherent to the J-tip injector.

Group A

The same initial timeout and sterile prep procedure will be followed for the use of local syringe and 25 gauge needle injection of 1% lidocaine ninety seconds prior to introduction of the regional block needle.

Group B

Eligibility Criteria

Age11 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Subjects between the ages of eleven and seventeen undergoing arthroscopic knee surgery.
  • Able to independently complete the Visual Analog pain scales.
  • Subjects who are neurologically intact at area of injection.
  • English speaking.

You may not qualify if:

  • Subjects with known allergies to lidocaine.
  • Presence of developmental delay.
  • Subjects with blood disorders affecting coagulation.
  • Subjects on blood thinners.
  • Subjects receiving chemotherapeutic agents.
  • Those who use or receive analgesia prior to procedure, except for acetaminophen or Non-steroidal anti-inflammatory medications.
  • Any other local sedation at the area of nerve block injection.
  • Non-English Speaking
  • Subjects with signs of skin infection or pathology at the injection site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orlando Health

Orlando, Florida, 32806, United States

Location

MeSH Terms

Conditions

Knee Injuries

Interventions

Syringes

Condition Hierarchy (Ancestors)

Leg InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Results Point of Contact

Title
Daryl C. Osbahr, MD
Organization
Orlando Health

Study Officials

  • Daryl C Osbahr, MD

    Orlando Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sports Medicine Orthopaedic physician

Study Record Dates

First Submitted

December 13, 2015

First Posted

January 7, 2016

Study Start

September 3, 2015

Primary Completion

August 28, 2019

Study Completion

August 28, 2019

Last Updated

May 5, 2020

Results First Posted

April 28, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations